Institution profile

医療法人社団豊饒会 J.YOSHIDA CLINIC

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 02C2608010 +2

Location

Prefecture
Tokyo
Address
渋谷区 恵比寿1-21-8 VORT恵比寿III 5階

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 再生医療普及協会 特定認定再生医療等委員会
  • 再生医療普及協会 認定再生医療等委員会

Public score

51.0/ 100

A · Review level
25.0 / 30
B · Technologies
15.9 / 35
C · Coverage
7.1 / 25
D · Class I / II technologies
2.9 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 441of 1736

Registered technologies
3
Areas covered
2

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 51.0
Public score →100

Registered technologies (3)

NK and immune cells 2
Registered technologies · Japanese originalTechnology areasPlan classification
人の免疫担当細胞の培養加工物を用いる免疫細胞治療。自家培養NK細胞を用いたNK細胞治療NK and immune cellsClass III
人の免疫担当細胞の培養加工物を用いる免疫細胞治療。 固相化CD3抗体+IL-2により活性化したαβT細胞治療。NK and immune cellsClass III
Skin 1
Registered technologies · Japanese originalTechnology areasPlan classification
自家培養線維芽細胞移植による皮膚の加齢変化(しわ、陥没、たるみ、毛孔開大、くま)に対する治療(肌再生医療)SkinClass II

Certified committee for regenerative medicine

  • 再生医療普及協会 特定認定再生医療等委員会
  • 再生医療普及協会 認定再生医療等委員会

Public document number

  • 02C2608010
  • 03C2409038
  • 03C2409039
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
自家培養線維芽細胞移植による皮膚の加齢変化(しわ、陥没、たるみ、毛孔開大、くま)に対する治療(肌再生医療)Class II再生医療普及協会 特定認定再生医療等委員会02C2608010
人の免疫担当細胞の培養加工物を用いる免疫細胞治療。自家培養NK細胞を用いたNK細胞治療Class III再生医療普及協会 認定再生医療等委員会03C2409038
人の免疫担当細胞の培養加工物を用いる免疫細胞治療。 固相化CD3抗体+IL-2により活性化したαβT細胞治療。Class III再生医療普及協会 認定再生医療等委員会03C2409039

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor